ESMCX
Price
$12.92
Change
-$0.08 (-0.62%)
Updated
Dec 17 closing price
VEURX
Price
$35.41
Change
-$0.14 (-0.39%)
Updated
Dec 17 closing price
Ad is loading...

ESMCX vs VEURX

Header iconESMCX vs VEURX Comparison
Open Charts ESMCX vs VEURXBanner chart's image
Invesco EQV Euro Small Company C
Price$12.92
Change-$0.08 (-0.62%)
VolumeN/A
CapitalizationN/A
Vanguard European Stock Investor
Price$35.41
Change-$0.14 (-0.39%)
VolumeN/A
CapitalizationN/A
ESMCX vs VEURX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESMCX vs. VEURX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMCX is a StrongBuy and VEURX is a Buy.

FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 23.3B vs. ESMCX (172M). ESMCX pays higher dividends than VEURX: ESMCX (3.59) vs VEURX (3.11). ESMCX was incepted earlier than VEURX: ESMCX (24 years) vs VEURX (35 years). ESMCX is a more actively managed with annual turnover of: 24.00 vs. VEURX (4.00). VEURX has a lower initial minimum investment than ESMCX: VEURX (0) vs ESMCX (1000). VEURX annual gain was more profitable for investors over the last year : 4.39 vs. ESMCX (0.71). VEURX return over 5 years is better than : 14.47 vs. ESMCX (12.00).
ESMCXVEURXESMCX / VEURX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years35 years-
Gain YTD-1.7792.219-80%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets172M23.3B1%
Annual Yield % from dividends3.593.11116%
Returns for 1 year0.714.3916%
Returns for 3 years-12.451.06-1,179%
Returns for 5 years12.0014.4783%
Returns for 10 years33.6827.76121%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OR18.980.01
+0.05%
Osisko Gold Royalties Ltd
HGTY10.85-0.13
-1.18%
Hagerty
TRU98.25-2.11
-2.10%
TransUnion
LFCR7.47-0.29
-3.74%
Lifecore Biomedical
INDP0.91-0.05
-5.31%
Indaptus Therapeutics